Ennova Health awards Futurs project “Identifying patients at risk of readmission within 30 days due to CDM”
The Ennova Health awards, presented by Diario Médico and Correo Farmacéutico, have recognized Futurs, the technology company of the Ribera healthcare group, for its project to “Identify patients at risk of readmission within 30 days due to a Major Diagnostic Cause (MDC)” as one of the most outstanding initiatives of 2025. These awards recognize the work of professionals, institutions, and companies…





